eLife (Jul 2018)
Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity
- Xue-Song Zhang,
- Jackie Li,
- Kimberly A Krautkramer,
- Michelle Badri,
- Thomas Battaglia,
- Timothy C Borbet,
- Hyunwook Koh,
- Sandy Ng,
- Rachel A Sibley,
- Yuanyuan Li,
- Wimal Pathmasiri,
- Shawn Jindal,
- Robin R Shields-Cutler,
- Ben Hillmann,
- Gabriel A Al-Ghalith,
- Victoria E Ruiz,
- Alexandra Livanos,
- Angélique B van ‘t Wout,
- Nabeetha Nagalingam,
- Arlin B Rogers,
- Susan Jenkins Sumner,
- Dan Knights,
- John M Denu,
- Huilin Li,
- Kelly V Ruggles,
- Richard Bonneau,
- R Anthony Williamson,
- Marcus Rauch,
- Martin J Blaser
Affiliations
- Xue-Song Zhang
- ORCiD
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Jackie Li
- ORCiD
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Kimberly A Krautkramer
- Department of Biomolecular Chemistry, Wisconsin Institute for Discovery, University of Wisconsin School of Medicine and Public Health, Madison, United States
- Michelle Badri
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States; Center for Data Science, New York University, New York, United States
- Thomas Battaglia
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Timothy C Borbet
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Hyunwook Koh
- Department of Population Health, New York University Langone Medical Center, New York, United States
- Sandy Ng
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Rachel A Sibley
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Yuanyuan Li
- Nutrition Research Institute, University of North Carolina at Chapel Hill School of Public Health, Kannapolis, United States
- Wimal Pathmasiri
- Nutrition Research Institute, University of North Carolina at Chapel Hill School of Public Health, Kannapolis, United States
- Shawn Jindal
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Robin R Shields-Cutler
- Computer Science and Engineering, BioTechnology Institute, University of Minnesota, St. Paul, United States
- Ben Hillmann
- Computer Science and Engineering, BioTechnology Institute, University of Minnesota, St. Paul, United States
- Gabriel A Al-Ghalith
- Computer Science and Engineering, BioTechnology Institute, University of Minnesota, St. Paul, United States
- Victoria E Ruiz
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Alexandra Livanos
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Angélique B van ‘t Wout
- Janssen Prevention Center London, Janssen Pharmaceutical Companies of Johnson and Johnson, London, United Kingdom
- Nabeetha Nagalingam
- Janssen Prevention Center London, Janssen Pharmaceutical Companies of Johnson and Johnson, London, United Kingdom
- Arlin B Rogers
- Department of Biomedical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, United States
- Susan Jenkins Sumner
- Nutrition Research Institute, University of North Carolina at Chapel Hill School of Public Health, Kannapolis, United States
- Dan Knights
- Computer Science and Engineering, BioTechnology Institute, University of Minnesota, St. Paul, United States
- John M Denu
- Department of Biomolecular Chemistry, Wisconsin Institute for Discovery, University of Wisconsin School of Medicine and Public Health, Madison, United States
- Huilin Li
- Department of Population Health, New York University Langone Medical Center, New York, United States
- Kelly V Ruggles
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States
- Richard Bonneau
- Center for Data Science, New York University, New York, United States
- R Anthony Williamson
- Janssen Prevention Center London, Janssen Pharmaceutical Companies of Johnson and Johnson, London, United Kingdom
- Marcus Rauch
- Janssen Prevention Center London, Janssen Pharmaceutical Companies of Johnson and Johnson, London, United Kingdom
- Martin J Blaser
- ORCiD
- Department of Medicine, New York University Langone Medical Center, New York, United States; Human Microbiome Program, New York University Langone Medical Center, New York, United States; Department of Microbiology, New York Uniersity Langone Medical Center, New York, United States
- DOI
- https://doi.org/10.7554/eLife.37816
- Journal volume & issue
-
Vol. 7
Abstract
The early-life intestinal microbiota plays a key role in shaping host immune system development. We found that a single early-life antibiotic course (1PAT) accelerated type 1 diabetes (T1D) development in male NOD mice. The single course had deep and persistent effects on the intestinal microbiome, leading to altered cecal, hepatic, and serum metabolites. The exposure elicited sex-specific effects on chromatin states in the ileum and liver and perturbed ileal gene expression, altering normal maturational patterns. The global signature changes included specific genes controlling both innate and adaptive immunity. Microbiome analysis revealed four taxa each that potentially protect against or accelerate T1D onset, that were linked in a network model to specific differences in ileal gene expression. This simplified animal model reveals multiple potential pathways to understand pathogenesis by which early-life gut microbiome perturbations alter a global suite of intestinal responses, contributing to the accelerated and enhanced T1D development.
Keywords